Welcome to CSNpharm! For Research Use Only!

CXCR

CXCR

Cat. No. Product Name CAS No. Information
CSN15996 WZ811 55778-02-4 WZ811 is a small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
CSN18633 UNBS5162 956590-23-1 UNBS5162 is a naphthalimide and a hydrolysis product of UNBS3157 that decreases CXCL chemokine expression in experimental prostate cancers and the mean antiproliferative activity IC50 value is 179 M for 9 cancer cell lines
CSN17557 SRT3190 1204707-73-2 SRT3190 is CXCR2 ligand.
CSN17556 SRT3109 1204707-71-0 SRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
CSN17197 SB-225002   182498-32-4 SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing 150-fold selectivity over CXCR1 and four other 7-TMRs.
CSN23103 SB 332235 276702-15-9 SB-332235 is a potent and specific CXCR2 antagonist. SB-332235 effectively inhibited CS-induced neutrophilia in a dose-dependent manner.
CSN23101 SB 265610 211096-49-0 SB-265610 is a potent CXCR2 antagonist that inhibits CINC-1-mediated but not C5a-mediated Ca2+ mobilization (IC50 values are 3.4 and 6800 nM respectively). It inhibits CINC-induced chemotaxis and attenuates neutrophil accumulation in inflammatory lung injury in vivo.
CSN18171 Reparixin L-lysine 266359-93-7 Reparixin L-lysine is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation,which has been shown to attenuate inflammatory responses in various injury models.
CSN15950 Reparixin 266359-83-5 Reparixin is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.
CSN12664 Plerixafor   110078-46-1 Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
CSN16151 Plerixafor 8HCl   155148-31-5 Plerixafor 8HCl is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
CSN18477 NBI-74330 855527-92-3 NBI-74330 is a small molecule antagonist for CXCR3, NBI-74330 demonstrates potent inhibition of (125)ICXCL10 and (125)ICXCL11 specific binding (K (i) of 1.5 and 3.2 nM, respectively.
CSN21269 MSX-130 4051-59-6 MSX-130 is CXCR4 Antagonist
CSN24505 JMS-17-2   1380392-05-1 JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM.
CSN22862 IT1t 2HCl 1092776-63-0 IT1t 2HCl is a potent CXCR4 antagonist with IC50 of 1.1 nM.
CSN22815 FC 131 606968-52-9 FC 131 is a CXCR4 antagonist with IC50 of 126 nM.
CSN15665 Baohuoside I 113558-15-9 Baohuoside I, a flavonoid, acts as an apoptosis inducer and a down-regulator of durvivin and cyclin D1 expression. It is used as an anti-cancer agent and can be isolated and purified from the roots of epimedium brevicornu Maxim.
CSN21987 AZD8797 911715-90-7 AZD8797 is an allosteric non-competitive and orally active modulator of the human CX3CR1 receptor which antagonizes CX3CR1 and CXCR2 with Kis of 3.9 and 2800 nM, respectively.
CSN18287 AMG-487 473719-41-4 AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
CSN18051 AMD 3465 185991-24-6 AMD 3465 is a potent, selective CXCR4 antagonist and exhibits 8-fold higher affinity than AMD 3100 and inhibits SDF-1-ligand binding (Ki 41.7 nM).
<< PREV 1 2 NEXT >>